TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value
$1.82−0.03 (-1.62%)
Close on Nov 12, 2026Market cap $21.07MP/E –Yield –
TherapeuticsMD cash
Cash and short-term investments held at the end of each period.
TherapeuticsMD's cash was $9.19M at Jun 30, 2026. For fiscal 2025 it was $7.48M, up 47.9% from the year before. Over ten years it grew -19.4% a year on average. The highest annual figure on record is $161.61M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.48M | +47.9% |
| FY2024 | Dec 31, 2024 | $5.06M | +16.9% |
| FY2023 | Dec 31, 2023 | $4.33M | -91.2% |
| FY2022 | Dec 31, 2022 | $49.32M | -24.0% |
| FY2021 | Dec 31, 2021 | $64.91M | -19.4% |
| FY2020 | Dec 31, 2020 | $80.49M | -50.0% |
| FY2019 | Dec 31, 2019 | $160.83M | -0.5% |
| FY2018 | Dec 31, 2018 | $161.61M | +27.1% |
| FY2017 | Dec 31, 2017 | $127.14M | -3.3% |
| FY2016 | Dec 31, 2016 | $131.53M | +103.3% |
| FY2015 | Dec 31, 2015 | $64.71M | +26.0% |
| FY2014 | Dec 31, 2014 | $51.36M | -5.2% |
| FY2013 | Dec 31, 2013 | $54.19M | +3388.4% |
| FY2012 | Dec 31, 2012 | $1.55M | +1128.8% |
| FY2011 | Dec 31, 2011 | $126.42K | -70.1% |
| FY2010 | Dec 31, 2010 | $422.94K | +256226.7% |
| FY2009 | Dec 31, 2009 | $165 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.19M | +51.4% |
| Q1 FY2026 | Mar 31, 2026 | $8.42M | +46.5% |
| Q4 FY2025 | Dec 31, 2025 | $7.48M | +47.9% |
| Q3 FY2025 | Sep 30, 2025 | $7.12M | +41.0% |
| Q2 FY2025 | Jun 30, 2025 | $6.07M | +16.0% |
| Q1 FY2025 | Mar 31, 2025 | $5.75M | +32.4% |
| Q4 FY2024 | Dec 31, 2024 | $5.06M | +16.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.05M | -50.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.23M | -61.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.34M | -74.8% |
| Q4 FY2023 | Dec 31, 2023 | $4.33M | -91.2% |
| Q3 FY2023 | Sep 30, 2023 | $10.17M | -84.4% |
| Q2 FY2023 | Jun 30, 2023 | $13.73M | -78.9% |
| Q1 FY2023 | Mar 31, 2023 | $17.25M | -73.5% |
| Q4 FY2022 | Dec 31, 2022 | $49.32M | -24.0% |
| Q3 FY2022 | Sep 30, 2022 | $65.12M | -37.9% |
| Q2 FY2022 | Jun 30, 2022 | $65.12M | -41.6% |
| Q1 FY2022 | Mar 31, 2022 | $65.12M | -52.7% |
| Q4 FY2021 | Dec 31, 2021 | $64.91M | -19.4% |
| Q3 FY2021 | Sep 30, 2021 | $104.84M | +31.7% |
| Q2 FY2021 | Jun 30, 2021 | $111.42M | -2.1% |
| Q1 FY2021 | Mar 31, 2021 | $137.62M | -19.1% |
| Q4 FY2020 | Dec 31, 2020 | $80.49M | -50.0% |
| Q3 FY2020 | Sep 30, 2020 | $79.63M | -48.7% |
| Q2 FY2020 | Jun 30, 2020 | $113.84M | -37.7% |
| Q1 FY2020 | Mar 31, 2020 | $170.10M | +38.4% |
| Q4 FY2019 | Dec 31, 2019 | $160.83M | -0.5% |
| Q3 FY2019 | Sep 30, 2019 | $155.33M | -18.2% |
| Q2 FY2019 | Jun 30, 2019 | $182.85M | +18.4% |
| Q1 FY2019 | Mar 31, 2019 | $122.88M | +14.5% |
| Q4 FY2018 | Dec 31, 2018 | $161.61M | +27.1% |
| Q3 FY2018 | Sep 30, 2018 | $190.00M | +28.1% |
| Q2 FY2018 | Jun 30, 2018 | $154.39M | +60.0% |
| Q1 FY2018 | Mar 31, 2018 | $107.35M | -5.4% |
| Q4 FY2017 | Dec 31, 2017 | $127.14M | -3.3% |
| Q3 FY2017 | Sep 30, 2017 | $148.29M | +0.5% |
| Q2 FY2017 | Jun 30, 2017 | $96.48M | – |
| Q1 FY2017 | Mar 31, 2017 | $113.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $131.53M | – |
| Q3 FY2016 | Sep 30, 2016 | $147.53M | – |
See a number that looks wrong?